The recent article “Two more Pioneer ACOs exit as new CMS model emerges” raises good questions about why half of the original 32 Pioneer accountable care organizations have dropped out of the program.
The Nov. 9 editorial “A green light for attacking Obamacare” is an excellent piece, and I agree with its assessment of the situation.
Regarding the Oct. 26 editorial “A bungled bundle”, bundled payments are nothing new.
Regarding the recent article “Top EHR vendors agree to interoperability metrics”, if vendors had focused on this from the start, we could be avoiding all this catch-up now.
Regarding the recent editorial “Keep the Cadillac tax”, the so-called Cadillac tax, unfortunately, gets caught in the cross-currents of three economic concerns, not all compatible with each other.
Regarding the Sept. 28 article “Medicare Advantage plans need better network adequacy oversight: GAO”, I have been following the debate on the changes in Medicare Advantage plans, especially in light of the enactment of the Affordable Care Act.
Although I have been a follower of your publication for some time, I was disturbed by an article in the Sept. 14 issue, “Cuts to Planned Parenthood have troubling impact on states.”
Regarding the recent article, “Readmissions may say more about patients than care”, I was the medical director at a hospital in Gary, Ind., brought in to turn around the emergency department, so I have seen underserved areas up close.
Regarding the Sept. 7 editorial “A better way to end balance billing”: It's an outrageous assumption that allowing one “provider” to decide how the allocation of reimbursement is to be distributed is a reasonable solution.
Regarding the recent article “80% of health IT leaders say their systems have been compromised”, the current U.S. health information technology system is engineered to guarantee that health data breaches will occur forever.
Regarding your recent story “Study fuels push for FDA e-cigarette regulation” (ModernHealthcare.com, Aug. 19), youth exposure to television e-cigarette advertisements, measured by target rating points, increased 256% from 2011 to 2013
Your article about Essure, “Delayed scrutiny: Reported problems with birth-control device expose gaps in postmarket oversight,” requires clarification.